Lawmakers attach user fees to CR, plan to revisit riders after mid-terms

Regulatory NewsRegulatory NewsAPIsBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy